Intraductal and cystic pancreatic neoplasia
Authors:
Markéta Hermanová
Authors‘ workplace:
I. ústav patologie LF MU a FN u sv. Anny v Brně
Published in:
Čes.-slov. Patol., 60, 2024, No. 2, p. 81-89
Category:
Reviews Article
Overview
The current WHO classification of digestive system tumours (2019) has presented the concept of diagnostics of intraductal and cystic neoplasms of the pancreas mostly based on integrated molecular data and evaluations of their malignant potential. Intraductal pancreatic neoplasms with ductal phenotype include microscopic precursor lesions of pancreatic ductal adenocarcinoma – the pancreatic intraepithelial neoplasia and macroscopic precursor lesions of pancreatic cancer, where intraductal papillary mucinous neoplasm represents the most common neoplasm of the pancreas with cystic appearance. Both intraductal oncocytic papillary neoplasm and intraductal tubulopapillary neoplasm are now classified as separate entities associated with less aggressive subtypes of pancreatic carcinoma and better prognosis. Clinical significance of microscopic pancreatic intraepithelial neoplasias is limited, in contrast to other intraductal neoplasms, which are presented as cystic and/or solid tumours by imaging methods with important consequences for further treatment and indication of surgical therapy (resection versus „watch and wait“ strategies). Neoplasms of nonductal origin, such as acinar cell carcinomas and neuroendocrine neoplasms, can uncommonly display an intraductal growth and their correct classification has a great clinical importance. Moreover, differential diagnostics of cystic pancreatic lesions include not only cystic and pseudocystically transformed neoplasms, but also a large spectrum of reactive, inflammatory and dysontogenetic cystic lesions.
Keywords:
pancreatic tumors – intraductal – cystic
Sources
- Storz P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol Hepatol 2017; 14(5): 296-304.
- Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher P. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas 2007; 35(3): 212-217.
- Reichert M, Blume K, Kleger A, Hartmann D, von Figura G. Developmental pathways direct pancreatic cancer initiation from its cellular origin. Stem Cells Int 2016; 2016: 9298535.
- Hämmerle M, Bergmann F. Seltene Pankreastumoren [Rare pancreatic tumors]. Pathologe 2021; 42(5): 484-490.
- Sato H, Liss AS, Mizukami Y. Large-duct pattern invasive adenocarcinoma of the pancreas-a variant mimicking pancreatic cystic neoplasms: A minireview. World J Gastroenterol 2021; 27(23): 3262-3278.
- Cornish TC, Hruban RH. Pancreatic intraepithelial neoplasia. Surg Pathol Clin 2011; 4(2): 523-535.
- Basturk O, Hong SM, Wood LD, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 2015; 39(12): 1730-1741.
- Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003; 16(10):996-1006.
- Kanda M, Matthaei H, Wu J, et al. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 2012; 142(4): 730-733.e9.
- Bartsch DK, Dietzel K, Bargello M, et al. Multiple small „imaging“ branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia? Fam Cancer 2013; 12(1): 89-96.
- Singh M, Maitra A. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology 2007; 7(1):9-19.
- Hosoda W, Chianchiano P, Griffin JF, et al. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4. J Pathol 2017; 242(1): 16-23.
- Hata T, Suenaga M, Marchionni L, et al. Genome-wide somatic copy number alterations and mutations in high-grade pancreatic intraepithelial neoplasia. Am J Pathol 2018; 188(7): 1723-1733.
- Hutchings D, Waters KM, Weiss MJ, et al. Cancerization of the pancreatic ducts: demonstration of a common and under-recognized process using immunolabeling of paired duct lesions and invasive pancreatic ductal adenocarcinoma for p53 and Smad4 expression. Am J Surg Pathol 2018; 42(11): 1556-1561.
- Matthaei H, Hong SM, Mayo SC, et al. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol 2011; 18(12): 3493-3499.
- Kleeff J, Michalski C, Kong B, et al. Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience. HPB Surg 2015; 2015: 847837.
- Valsangkar NP, Morales-Oyarvide V, Thayer SP et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery 2012; 152(3 Suppl 1): S4-S12.
- Adsay V, Mino-Kenudson M, Furukawa T, et al. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona consensus meeting. Ann Surg 2016; 263(1): 162-177.
- Marchegiani G, Mino-Kenudson M, Ferrone CR et al. Patterns of recurrence after resection of IPMN: Who, when, and how? Ann Surg 2015; 262(6): 1108-1114.
- Marchegiani G, Mino-Kenudson M, Sahora K, et al. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg 2015; 261(5): 976-983.
- Pergolini I, Sahora K, Ferrone CR, et al. Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center. Gastroenterology 2017; 153(5): 1284-1294.e1.
- Kloth C, Haggenmüller B, Beck A, et al. Diagnostic, structured classification and therapeutic approach in cystic pancreatic lesions: systematic findings with regard to the European guidelines. Diagnostics (Basel) 2023; 13(3): 454.
- Oyama H, Tada M, Takagi K, et al. Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms. Gastroenterology 2020; 158(1): 226-237.e5.
- Reid MD, Lewis MM, Willingham FF, Adsay NV. The evolving role of pathology in new developments, classification, terminology, and diagnosis of pancreatobiliary neoplasms. Arch Pathol Lab Med 2017; 141(3): 366-380.
- Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 2006; 30(12): 1561-1569.
- Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005; 447(5): 794-799.
- Tan MC, Basturk O, Brannon AR, et al. GNAS and KRAS mutations define separate progression pathways in intraductal papillary mucinous neoplasm-associated carcinoma. J Am Coll Surg 2015; 220(5): 845-854.e1.
- Ban S, Naitoh Y, Ogawa F, Shimizu Y, Shimizu M, Yasumoto A, Koyama I. Intraductal papillary mucinous neoplasm (IPMN) of the gastric-type with focal nodular growth of the arborizing papillae: a case of high-grade transformation of the gastric-type IPMN. Virchows Arch 2006; 449(1): 112-116.
- Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001; 25(1): 26-42.
- Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 2011; 60(4): 509-516.
- Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002; 15(10): 1087-1095.
- Amato E, Molin MD, Mafficini A, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol 2014; 233(3): 217-227.
- Mino-Kenudson M, Fernández-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011; 60(12): 1712-1720.
- Gill AJ, Klimstra DS, Lam AK, Washington MK. Tumours of the pancreas. In: WHO Classification of Tumours. Digestive System Tumours. Edited by The WHO Classification of Tumours Editorial Board (5th ed). Lyon, IARC; 2019: 295-373.
- Wang T, Askan G, Adsay V, et al. Intraductal oncocytic papillary neoplasms: clinical-pathologic characterization of 24 cases, with an emphasis on associated invasive carcinomas. Am J Surg Pathol 2019; 43(5): 656-661.
- Adsay NV, Adair CF, Heffess CS, Klimstra DS. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996; 20(8): 980-994.
- Mattiolo P, Hong SM, Paolino G, et al. CD117 is a specific marker of intraductal papillary mucinous neoplasms (IPMN) of the pancreas, oncocytic subtype. Int J Mol Sci 2020; 21(16): 5794.
- Basturk O, Chung SM, Hruban RH, et al. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas. Virchows Arch 2016; 469(5): 523-532.
- Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. J Am Coll Surg 2015; 220(5): 839-844.
- Basturk O, Adsay V, Askan G, et al. Intraductal tubulopapillary neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 Cases. Am J Surg Pathol 2017; 41(3): 313-325.
- Basturk O, Berger MF, Yamaguchi H, et al. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma. Mod Pathol 2017; 30(12): 1760-1772.
- Kuan LL, Dennison AR, Garcea G. Intraductal tubulopapillary neoplasm of the pancreas and bile duct: a review. Pancreas 2020; 49(4): 498-502.
- Basturk O, Zamboni G, Klimstra DS, et al. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol 2007; 31(3): 363-370.
- Ishikawa T, Ohno E, Mizutani Y, Iida T, Kawashima H. Pancreatic acinar cell carcinoma with predominant extension into the main pancreatic duct: A case report. DEN Open 2022; 2(1): e96.
- Kayahara M, Onishi I, Makita N, et al. Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report. Surg Case Rep 2021; 7(1): 90.
- La Rosa S, Franzi F, Marchet S, et al. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch 2009; 454(2): 133-142.
- Chetty R, El-Shinnawy I. Intraductal pancreatic neuroendocrine tumor. Endocr Pathol 2009; 20(4): 262-266.
- Schiavo Lena M, Cangi MG, Pecciarini L, et al. Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor. Virchows Arch 2021; 478(6): 1215-1219.
- Jais B, Rebours V, Malleo G, et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut 2016; 65(2): 305-312.
- Kosmahl M, Wagner J, Peters K, Sipos B, Klöppel G. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 2004; 28(3): 339-346.
- Slukvin II, Hafez GR, Niederhuber JE, Warner TF. Combined serous microcystic adenoma and well-differentiated endocrine pancreatic neoplasm: a case report and review of the literature. Arch Pathol Lab Med 2003; 127(10): 1369-1372.
- Kim SG, Wu TT, Lee JH, et al. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Pathol 2003; 16(11): 1086-1094.
- Kosmahl M, Pauser U, Peters K, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004; 445(2): 168-178.
- Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23(4): 410-422.
- Fukushima N, Zamboni G. Mucinous cystic neoplasms of the pancreas: update on the surgical pathology and molecular genetics. Semin Diagn Pathol 2014; 31(6): 467-474.
- Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2002; 26(4): 466-471.
- Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 2011; 108(52): 2118821193.
Labels
Anatomical pathology Forensic medical examiner ToxicologyArticle was published in
Czecho-Slovak Pathology
2024 Issue 2
Most read in this issue
- Current diagnostic and treatment options for pancreatic cancer in 2024
- Calcific Aortic Stenosis – Inflammatory Disease
- Intraductal and cystic pancreatic neoplasia
- Pitfalls of cytological diagnosis of tumours of the pancreaticobiliary tract